Aptevo Therapeutics (APVO) Stock: Buy, Sell, or Hold?
APVO - Aptevo Therapeutics Inc
$1.82
-0.01 (-0.55%)
▼
5d:
+6.43%
30d:
-48.0%
90d:
-62.55%
WAIT
LOW Confidence
Analysis Updated: Sep 11, 2026 12:00 AM ET
Earnings: Nov 05, 2026
Get Alerted When APVO Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: APVO shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: APVO shows conflicting indicators. Wait for confirmation before entering.
In-depth Analysis How we analyze
Valuation Analysis: APVO is currently trading at $1.82, which is considered oversold relative to its 30-day fair value range of $1.98 to $3.55.
Technical Outlook: Technically, APVO is in a strong downtrend. Immediate support is located at $1.37, while resistance sits at $2.77.
Market Sentiment: APVO scores 60/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $25.50 (+1301.1%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, APVO is in a strong downtrend. Immediate support is located at $1.37, while resistance sits at $2.77.
Market Sentiment: APVO scores 60/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $25.50 (+1301.1%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$1.98 -
$3.55
Company Quality Score
46/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
94.7%
All Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 1301.1% below Wall St target ($25.50)
- WARNING: Composite score 46/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$1.98 -
$3.55
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$1.37
Resistance Level
$2.77
Current Trend
Strong Downtrend
Technical data as of
Sep 11, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-0.17
Wall Street Target
$25.50
(+1301.1%)
Revenue Growth (YoY)
-100.0%
Share & Embed Analysis
Last updated: September 13, 2026 2:08 PM ET
Data refreshes hourly during market hours. Next update: 3:08 PM
Data refreshes hourly during market hours. Next update: 3:08 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is APVO showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ALNY
Alnylam Pharmaceuticals … |
STRONG BUY
30 analysts |
$371 | 43 HOLD |
|
ONC
BeiGene, Ltd. |
STRONG BUY
24 analysts |
$432 | 48 HOLD |
|
VRTX
Vertex Pharmaceuticals I… |
BUY
34 analysts |
$569 | 38 SELL |
|
ASND
Ascendis Pharma AS |
STRONG BUY
16 analysts |
$314 | 47 HOLD |
|
APLS
Apellis Pharmaceuticals … |
BUY
22 analysts |
$41 | 50 HOLD |
